Man Group’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100,145
Closed -$2.19M 2383
2025
Q4
$2.19M Buy
100,145
+24,431
+32% +$507K ﹤0.01% 1421
2025
Q3
$1.63M Buy
75,714
+19,650
+35% +$441K ﹤0.01% 1501
2025
Q2
$1.44M Buy
56,064
+31,849
+132% +$932K ﹤0.01% 1521
2025
Q1
$886K Buy
24,215
+14,286
+144% +$491K ﹤0.01% 1615
2024
Q4
$305K Buy
9,929
+1,358
+16% +$45.1K ﹤0.01% 1784
2024
Q3
$323K Buy
+8,571
New +$330K ﹤0.01% 1762
2022
Q4
Sell
-7,374
Closed -$263K 2004
2022
Q3
$263K Buy
+7,374
New +$306K ﹤0.01% 1706
2022
Q2
Hold
0
1684

Other funds holding ATEX

Man Group's ATEX Position: Q1 2026 in Review

Man Group sold out of Anterix (ATEX) in Q1 2026, closing a stake of 100,145 shares — an estimated $2.19M sold.

Man Group first reported a position in ATEX in Q3 2022 and held it in 7 quarters. The position peaked at $2.19M in Q4 2025. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Man Group reported no remaining Anterix position as of Q1 2026 after selling out during the quarter.
  • Man Group sold 100,145 Anterix shares in Q1 2026, an estimated $2.19M.
  • Man Group first reported a position in Anterix in Q3 2022 and held it in 7 quarters.
  • Man Group's Anterix position peaked at $2.19M in Q4 2025.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.